SOLARABSESolara Active Pharma Sciences LtdMediumNeutral
Announced Fri, 15 May · 14:28 IST

Solara Active Pharma Sciences Limited has informed the exchange regarding the appointment of Cost Auditor and Internal Auditor for the FY 2026-27

Management Changes View source PDF

SOLARA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+10.5%1-day move
₹506.55
prior close
₹579.20
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.6+0.9+0.4-0.3+10.5+15.5+13.7+11.2+7.8+10.9+3.3+18.1+14.2
Up moveDown movePending
AI summary

Solara Active Pharma Sciences Limited has announced the re-appointment of its auditors for FY 2026-27. The Board approved re-appointing M/s. Grant Thornton Bharat LLP as Internal Auditors and Mr. K. Suryanarayanan as Cost Auditors. Grant Thornton is a leading professional services firm providing assurance, consulting, tax, and risk services. Mr. Suryanarayanan is a Fellow member of the Institute with over two decades of experience in Finance, Accounts, Costing, and Taxation. Both appointments are effective May 15, 2026, for the financial year 2026-27.

Likely market impact

This is a routine governance filing with no material impact on shareholders. The company is maintaining continuity in its audit functions with experienced professionals.